
Overview
Charles Geyer, MD, specializes in breast medical oncology and is certified in medical oncology and internal medicine by the American Board of Internal Medicine. He practices at the UPMC Magee Womens Hospital. He completed his medical degree at Texas Tech University Health Science Center, residency at Baylor College of Medicine, chief residency at Baylor College of Medicine and medical oncology fellowship at Baylor College of Medicine.
Dr. Geyer is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Febrile Neutropenia, and Menopause.
Dr. Geyer is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 108 peer reviewed articles and participating in 2 clinical trials. Dr. Geyer is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Halket Street, Suite 4628, Pittsburgh, PA 15213
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
UPMC Presbyterian
Jason Luke is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Luke is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, and Liver Embolization.
UPMC Magee-Womens Gynecologic Oncology
Dr. Sukumvanich is a specialized surgeon and gynecologic oncologist, specializing in the treatment of gynecologic and breast cancers. He serves as an assistant professor in the School of Medicine, and his research centers on the genetic causes of ovarian and breast cancers, and also cancer informatics (the science of analyzing large amounts of information). Dr. Sukumvanich is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vaginal Cancer, Vulvar Cancer, Vulvectomy, and Lymphadenectomy. Dr. Sukumvanich is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Sukumvanich is currently accepting new patients.
Upmc Division Of Surgical Oncology
Diwakar Davar, MBBS, M.Sc is an assistant professor of medicine and a medical oncologist/hematologist. He specializes in the management of advanced melanoma and the development of early phase studies to test novel immunotherapeutic approaches to treat advanced cancers.;. Dr. Davar is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Uveal Melanoma, and Gamma Knife Radiosurgery. Dr. Davar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Davar is currently accepting new patients.
UPMC Magee-Womens Gynecologic Oncology
Jamie Lesnock, MD, specializes in gynecologic oncology and is certified in gynecologic oncology and obstetrics and gynecology by the American Board of Obstetrics and Gynecology. She practices at University of Pittsburgh Physicians, Department of Obstetrics and Gynecology and is affiliated with UPMC Mercy, UPMC Presbyterian, UPMC Shadyside, UPMC Magee-Womens Hospital, and UPMC Passavant. She completed her residency at University of Pittsburgh School of Medicine and her medical degree at Vanderbilt University School of Medicine. Dr. Lesnock is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Ureteral Reconstruction, and Tissue Biopsy. Dr. Lesnock is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Lesnock is currently accepting new patients.
Frequently Asked Questions about Dr. Charles E. Geyer
How do I make an appointment with Dr. Charles E. Geyer?
You can book an appointment with Dr. Charles E. Geyer by calling their office at 412-530-6328. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Charles E. Geyer a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Charles E. Geyer is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Charles E. Geyer specialize in?
While Dr. Charles E. Geyer is a Oncology, they have specific expertise in Breast Cancer, Triple-Negative Breast Cancer, and Febrile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Charles E. Geyer participate in research or clinical trials?
Yes. Dr. Charles E. Geyer has published 108 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Charles E. Geyer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Charles E. Geyer accept my insurance?
Dr. Charles E. Geyer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-530-6328 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Geyer isElite. Learn about Breast Cancer.
- Distinguished
- Triple-Negative Breast CancerDr. Geyer isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Febrile NeutropeniaDr. Geyer isAdvanced. Learn about Febrile Neutropenia.
- MenopauseDr. Geyer isAdvanced. Learn about Menopause.
- Experienced
- AngiosarcomaDr. Geyer isExperienced. Learn about Angiosarcoma.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Inflammatory Breast CancerDr. Geyer isExperienced. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Geyer isExperienced. Learn about Paget Disease of the Breast.
- PIK3CA-Related Overgrowth SpectrumDr. Geyer isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.



